Zobrazeno 1 - 10
of 188
pro vyhledávání: '"biolimus‐eluting stent"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Cardiovascular and Thoracic Research, Vol 3, Iss 4, Pp 113-116 (2011)
Introduction: Drug-eluting stents (DES) have significantly decreased the need for repeat coronary revascularization but concerns remain regarding the safety of first and second generation DES. We compared the safety and efficacy of a biolimus-eluting
Externí odkaz:
https://doaj.org/article/98da11c2bc854ec8a676e0d3747d36ff
Autor:
Gennaro Sardella, Rossella Fattori, Luca Testa, Altin Palloshi, Luca Arrigoni, Antonio Colombo, Mauro Chiarito, Andrea Scotti, Rosario Parisi, Italian Nobori Stent ProspectIve REgistry, Alberto Cappelletti, Cosmo Godino, Riccardo Colantonio, Matteo Montorfano, Dennis Zavalloni Parenti, Gianfranco Aprigliano, Alberto Margonato, Shahram Moshiri, Diego Milazzo, Carlo Andrea Pivato, AmphilimuS iTalian mUlticenTre rEgistry (Astute) investigators, Francesco Bedogni, Francesco Melillo, Annamaria Nicolino, Nicola Locuratolo, Patrizia Presbitero, David Rutigliano, Carlo Briguori, Michael Donahue
Publikováno v:
International Journal of Cardiology. 245:69-76
Objectives This study sought to compare clinical outcome of polymer-free amphilimus-eluting stent (PF-AES) versus biodegradable-polymer biolimus-eluting stent (BD-BES) in âall-comerâ diabetes mellitus (DM) and non-DM patients who underwent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b9319e0062d367cef8989c1ed2801d2
https://doi.org/10.1016/j.ijcard.2017.06.028
https://doi.org/10.1016/j.ijcard.2017.06.028
Autor:
Walter Desmet, Andreas S. Triantafyllis, Efstathios D. Pagourelias, Christophe Dubois, Johan Bennett, Keir McCutcheon, Tom Adriaenssens, Peter Sinnaeve
Publikováno v:
Cardiology Journal. 25:470-478
Background: To evaluate long-term clinical outcomes after treatment of complex bifurcation lesions with the AXXESS dedicated self-expanding biolimus A9-eluting bifurcation stent. Methods: Between 2004 and 2013, 123 patients with complex bifurcation l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab14f82ce3817c1ef43bce0bc648229b
https://doi.org/10.5603/cj.a2017.0141
https://doi.org/10.5603/cj.a2017.0141
Autor:
Giulio G. Stefanini, Cosmo Godino, Astute Investigators, Gennaro Sardella, Rudi-Free, Mauro Chiarito
Publikováno v:
JACC: Cardiovascular Interventions. 12:1745-1747
Despite impressive improvements in drug-eluting stent (DES) technologies, patients with diabetes remain at high risk for adverse events after percutaneous revascularization. Among novel DES, the Cre8 polymer-free amphilimus-eluting stent (AES) has sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::476251a73c11172e2cbe02f6006c1be8
https://doi.org/10.1016/j.jcin.2019.04.029
https://doi.org/10.1016/j.jcin.2019.04.029
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Henrik Steen Hansen, Evald Høj Christiansen, Johnny Kahlert, Bent Raungaard, Michael Maeng, Lisette Okkels Jensen, Lars Jakobsen, Phillip Freeman, Martin Kirk Christensen, Anders Junker, Julia Ellert, Christian Juhl Terkelsen, Manijeh Noori, Kirstine Hansen
Publikováno v:
Journal of the American College of Cardiology. 78:B62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a29c6eb438512811dbfca2d64b91f72e
https://doi.org/10.1016/j.jacc.2021.09.1004
https://doi.org/10.1016/j.jacc.2021.09.1004
Autor:
Thierry Lefèvre, Janusz Lipiecki, Raphy Levy, Marc Eric Moulichon, Bernard Karsenty, Luc Maillard, François Brunelle, Eric Maupas, Fabien de Poli, Benjamin Faurie
Publikováno v:
Catheterization and Cardiovascular Interventions. 90:890-897
Objectives The French Ebiomatrix registry aimed to confirm the results of the Leaders trial in an all-comer population in France. Background The Leaders trial showed the Biolimus-eluting-sent (BES) to be equivalent to the Cypher stent in terms of saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13b53f5d9763b57f895a932aaeb0312b
https://doi.org/10.1002/ccd.27081
https://doi.org/10.1002/ccd.27081
Autor:
Maupas, Eric, Lipiecki, Janusz, Levy, Raphy, Faurie, Benjamin, Karsenty, Bernard, Moulichon, Marc Eric, Brunelle, François, Maillard, Luc, de Poli, Fabien, Lefèvre, Thierry
Publikováno v:
Catheterization and Cardiovascular Interventions
Objectives The French Ebiomatrix registry aimed to confirm the results of the Leaders trial in an all‐comer population in France. Background The Leaders trial showed the Biolimus‐eluting‐sent (BES) to be equivalent to the Cypher stent in terms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::72ddb8955840222583ff24f5232811aa
http://europepmc.org/articles/PMC5724651
http://europepmc.org/articles/PMC5724651
Publikováno v:
Ellert, J, Antonsen, L & Jensen, L O 2017, ' Early restenose in a polymer-free Biolimus A9-coated stent (BioFreedom) : A case report based on optical coherence tomography ', Cardiovascular Revascularization Medicine, vol. 18, no. 3, pp. 207-211 . https://doi.org/10.1016/j.carrev.2016.08.015
An 81-year-old male patient with a severe de novo coronary artery stenosis in the proximal left anterior descending artery was treated with a BioFreedom stent (3.5 × 11 mm), three months later, the patient was re-admitted with chest pain and slightl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eafefe1b4b936dbf1c446dd5ba5fedb4
https://doi.org/10.1016/j.carrev.2016.08.015
https://doi.org/10.1016/j.carrev.2016.08.015